ArticleBiologics : targets & therapy2023

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis.

Jolijn R van Leeuwen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.